GlaxoSmithKline (India)

GlaxoSmithKline (India)

GSK plc is a British multinational pharmaceutical and biotechnology company with headquarters in London. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for GlaxoSmithKline (India), India, covering academic research published from 2001 to 2023. Read More.


Open Access Percentage

64%


Total
Publications

1.4K


Total Open
Publications

889


Total
Citations

47K


Open Access
Percentage

64%


Total
Publications

1.4K


Total Open
Publications

889


Total
Citations

47K

Wikipedia

Website

download

Breakdown

28% 26% 10% 36%

Publisher Open

28%

Both

26%

Other Platform Open

10%

Closed

36%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090Total Publications
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

22%OA Journal

OA Journal 22%

167

Hybrid 31%

228

No Guarantees 47%

347

Other Platform Open

Domain 77%

387

Institution 26%

130

Preprint 8%

38

Public 7%

33

Other Internet 6%

31

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
381
Europe PMC
Domain
249
Semantic Scholar
Public
31
Research Square
Preprint
21
bioRxiv
Preprint
18
University College London - UCL Discovery
Institution
16
University of Cambridge - Apollo
Institution
13
University of North Carolina at Chapel Hill - Carolina Digital Repository
Institution
9
University of Dundee - Discovery Research Portal
Institution
9
University of Strathclyde - Strathprints: The University of Strathclyde institutional repository
Institution
8
1 / 11

Data updated 8 December 2024

Share

Share

Share